Pulmonary arterial hypertension Trials in Austell, United States
Conditions / Pulmonary arterial hypertension / Austell, United States
Clinical trials for Pulmonary arterial hypertension investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT01908699 | Beraprost-314d Added-on to Tyvaso® (BEAT) | COMPLETED | PHASE3 |
| NCT01106014 | Selexipag (ACT-293987) in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT01266265 | Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies | COMPLETED | — |
| NCT02725372 | Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH | TERMINATED | PHASE3 |
| NCT03197688 | Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States | COMPLETED | — |
| NCT01112306 | ACT-293987 in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy | COMPLETED | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |